Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Rayonier
RYN
$6.45B
| $514K | ﹤0.01% |
19,978
-24,150
| -55% | -$618K |
|
|
XEC
3327
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $514K | ﹤0.01% |
4,300
+900
| +26% | +$117K |
|
|
SSRI
3328
CALL
DELISTED
Silver Standard Resources
SSRI
| $514K | ﹤0.01% |
48,400
-2,100
| -4% | -$22.2K |
|
3329
PUT
Stryker
SYK
$129B
| $513K | ﹤0.01% |
3,900
-121,500
| -97% | -$15.3M |
|
3330
Invesco Senior Loan ETF
BKLN
$6.81B
| $512K | ﹤0.01% |
+22,000
| New | +$513K |
|
3331
CALL
Celanese
CE
$4.82B
| $512K | ﹤0.01% |
5,700
-6,800
| -54% | -$594K |
|
3332
iShares 1-3 Year International Treasury Bond ETF
ISHG
$828M
| $512K | ﹤0.01% |
6,522
| – | – |
|
3333
National Health Investors
NHI
$3.65B
| $512K | ﹤0.01% |
7,048
-2,699
| -28% | -$198K |
|
|
AHT
3334
Ashford Hospitality Trust
AHT
$21M
| $511K | ﹤0.01% |
81
+76
| +1,520% | +$534K |
|
3335
PUT
J.M. Smucker
SJM
$12.7B
| $511K | ﹤0.01% |
3,900
+100
| +3% | +$13.6K |
|
3336
CALL
Cedar Fair
FUN
$1.61B
| $509K | ﹤0.01% |
7,500
-2,200
| -23% | -$144K |
|
|
CCF
3337
DELISTED
Chase Corporation
CCF
| $509K | ﹤0.01% |
5,343
-6,207
| -54% | -$559K |
|
3338
Clearwater Paper
CLW
$369M
| $508K | ﹤0.01% |
9,090
+5,283
| +139% | +$313K |
|
3339
National CineMedia
NCMI
$378M
| $508K | ﹤0.01% |
4,020
-264
| -6% | -$35.6K |
|
3340
Vanguard Financials ETF
VFH
$13.7B
| $507K | ﹤0.01% |
8,384
| – | – |
|
|
MCRN
3341
DELISTED
Milacron Holdings Corp.
MCRN
| $507K | ﹤0.01% |
27,293
+24,381
| +837% | +$442K |
|
3342
Columbia Banking Systems
COLB
$8.78B
| $506K | ﹤0.01% |
12,984
+10,939
| +535% | +$441K |
|
3343
Advanced Drainage Systems
WMS
$11.4B
| $506K | ﹤0.01% |
23,076
-7,153
| -24% | -$162K |
|
|
MDR
3344
DELISTED
McDermott International
MDR
| $506K | ﹤0.01% |
24,963
-3,018
| -11% | -$66.5K |
|
3345
Charles River Laboratories
CRL
$12.8B
| $505K | ﹤0.01% |
5,607
+4,362
| +350% | +$370K |
|
3346
Casella Waste Systems
CWST
$5.75B
| $505K | ﹤0.01% |
35,785
+3,543
| +11% | +$44K |
|
|
MEET
3347
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $505K | ﹤0.01% |
85,765
-127,466
| -60% | -$647K |
|
|
PTLA
3348
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $501K | ﹤0.01% |
12,800
+7,400
| +137% | +$236K |
|
3349
Globus Medical
GMED
$11B
| $500K | ﹤0.01% |
16,880
-168,336
| -91% | -$4.59M |
|
3350
MarketAxess Holdings
MKTX
$5.72B
| $500K | ﹤0.01% |
2,667
-26,586
| -91% | -$4.82M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.